Ultralife (ULBI) Gross Margin (2010 - 2026)

Ultralife's Gross Margin history runs 17 years deep, the most recent figure standing at 21.31% for Q1 2026.

• On a quarterly basis, Gross Margin fell 381.0% year-over-year to 21.31% in Q1 2026; TTM through Mar 2026 was 23.1%, a 206.0% decrease from a year earlier, with the FY2025 full-year figure at 24.07%, down 165.0% from the prior year.
• Gross Margin fell to 21.31% in Q1 2026 per ULBI's latest filing, from 24.87% in the prior quarter.
• Across five years, Gross Margin topped out at 27.36% in Q1 2024 and bottomed at 20.21% in Q3 2022.
• The 5-year median for Gross Margin is 24.17% (2024), against an average of 23.99%.
• Across the five-year window, Gross Margin plunged 396 bps in 2022 and soared 455 bps in 2023, its largest moves.
• Year by year, Gross Margin stood at 22.38% in 2022, then grew by 14 bps to 25.59% in 2023, then slipped by 6 bps to 24.17% in 2024, then rose by 3 bps to 24.87% in 2025, then declined by 14 bps to 21.31% in 2026.
• Per Business Quant, the three latest ULBI Gross Margin figures stand at 21.31% (Q1 2026), 24.87% (Q4 2025), and 22.18% (Q3 2025).